UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain

European journal of neurology, 2009-09, Vol.16 (9), p.1041-1048

2009

Volltextzugriff (PDF)

O80 Évaluation de l’effet de la duloxétine dans la neuropathie diabétique périphérique douloureuse

Diabetes & metabolism, 2009, Vol.35, p.A21-A21

2009

Volltextzugriff (PDF)

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

European psychiatry, 2006-09, Vol.21 (6), p.367-378

2006

Volltextzugriff (PDF)

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

Psychopharmacologia, 1999-11, Vol.147 (2), p.162-167

1999

Volltextzugriff (PDF)

Tackling a Major Deficiency of Diversity in Alzheimer’s Disease Therapeutic Trials: An CTAD Task Force Report

The journal of prevention of Alzheimer's disease, 2022, Vol.9 (3), p.388-392

2022

Volltextzugriff (PDF)

Duloxetine vs. placebo in patients with painful diabetic neuropathy

Pain (Amsterdam), 2005-07, Vol.116 (1), p.109-118

2005

Volltextzugriff (PDF)

P.1.k.033 A new platform to improve quality of PANNS and MADRS administration

European neuropsychopharmacology, 2015-09, Vol.25, p.S371-S372

2015

Volltextzugriff (PDF)

EPA-1780 – Are different methods to reduce placebo response in cns trials mutually exclusive or have additive effects?

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

Psychopharmacology, 1995-09, Vol.121 (1), p.66-72

1995

Volltextzugriff (PDF)

Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report

The journal of prevention of Alzheimer's disease, 2020, Vol.7 (3), p.152-157

2020

Volltextzugriff (PDF)

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression

International journal of clinical practice (Esher), 2007-08, Vol.61 (8), p.1337-1348

2007

Volltextzugriff (PDF)

Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine

Journal of clinical psychopharmacology, 2004-08, Vol.24 (4), p.389-399

2004

Volltextzugriff (PDF)

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

European neuropsychopharmacology, 2004-12, Vol.14 (6), p.457-470

2004

Volltextzugriff (PDF)

Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

Behavioural brain research, 1996, Vol.73 (1-2), p.43-46

1996

Volltextzugriff (PDF)

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression

Current pharmaceutical design, 2005-05, Vol.11 (12), p.1475

2005

Volltextzugriff (PDF)

P.8.a.015 The power of expectation bias

European neuropsychopharmacology, 2011, Vol.21, p.S619-S619

2011

Volltextzugriff (PDF)

P.8.a.014 The importance of rigor in post-baseline assessments in CNS clinical trials

European neuropsychopharmacology, 2011, Vol.21, p.S618-S619

2011

Volltextzugriff (PDF)

Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists

Psychopharmacologia, 1995-05, Vol.119 (1), p.47-54

1995

Volltextzugriff (PDF)

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder

Journal of psychopharmacology (Oxford), 2008-06, Vol.22 (4), p.417-425

2008

Volltextzugriff (PDF)

Acute and Chronic Antidepressant Drug Treatment in the Rat Forced Swimming Test Model of Depression

Experimental and clinical psychopharmacology, 1997-05, Vol.5 (2), p.107-112

1997

Volltextzugriff (PDF)

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

The journal of clinical psychiatry, 2005-06, Vol.66 (6), p.686

2005

Volltextzugriff (PDF)

Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine

Journal of clinical psychopharmacology, 2005-04, Vol.25 (2), p.132-140

2005

Volltextzugriff (PDF)

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

International clinical psychopharmacology, 2008-05, Vol.23 (3), p.161

2008

Volltextzugriff (PDF)

726

The journal of pain, 2007-04, Vol.8 (4), p.S32-S32

2007

Volltextzugriff (PDF)

A phase 1b study of potential safety and pharmacokinetic interactions between cocaine and EMB-001, with exploratory efficacy measures

European neuropsychopharmacology, 2017-10, Vol.27, p.S1073

2017

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(125)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(67)
Humans
(52)
Psychiatry
(50)
Male
(45)
Female
(40)
Biological And Medical Sciences
(38)
Psychology. Psychoanalysis. Psychiatry
(36)
Adult
(35)
Double-Blind Method
(35)
Duloxetine Hydrochloride
(35)
Medical Sciences
(34)
Treatment Outcome
(34)
Thiophenes - Therapeutic Use
(32)
Psychopharmacology
(30)
Middle Aged
(29)
Neuropharmacology
(28)
Pharmacology. Drug Treatments
(28)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(25)
Duloxetine
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain

O80 Évaluation de l’effet de la duloxétine dans la neuropathie diabétique périphérique douloureuse

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

Tackling a Major Deficiency of Diversity in Alzheimer’s Disease Therapeutic Trials: An CTAD Task Force Report

Duloxetine vs. placebo in patients with painful diabetic neuropathy

P.1.k.033 A new platform to improve quality of PANNS and MADRS administration

EPA-1780 – Are different methods to reduce placebo response in cns trials mutually exclusive or have additive effects?

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression

Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression

P.8.a.015 The power of expectation bias

P.8.a.014 The importance of rigor in post-baseline assessments in CNS clinical trials

Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder

Acute and Chronic Antidepressant Drug Treatment in the Rat Forced Swimming Test Model of Depression

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

726

A phase 1b study of potential safety and pharmacokinetic interactions between cocaine and EMB-001, with exploratory efficacy measures

Suchergebnisse filtern